{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:01:52Z","timestamp":1793278912500,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00198-020-05664-x","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T18:03:07Z","timestamp":1604080987000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Methotrexate osteopathy: five cases and systematic literature review"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-8160","authenticated-orcid":false,"given":"F.","family":"Robin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cadiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-D.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Guggenbuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"5664_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/1097-0142(197003)25:3<580::aid-cncr2820250313>3.0.co;2-m","volume":"25","author":"AH Ragab","year":"1970","unstructured":"Ragab AH, Frech RS, Vietti TJ (1970) Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580\u2013585. https:\/\/doi.org\/10.1002\/1097-0142(197003)25:3<580::aid-cncr2820250313>3.0.co;2-m","journal-title":"Cancer"},{"key":"5664_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Po\u00f3r G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960\u2013977. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"key":"5664_CR3","doi-asserted-by":"publisher","unstructured":"Coates LC, Gossec L, Ramiro S, et al. (2017) New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: process and challenges faced. Rheumatology kew390. https:\/\/doi.org\/10.1093\/rheumatology\/kew390","DOI":"10.1093\/rheumatology\/kew390"},{"key":"5664_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/bmj.287.6394.762-a","volume":"287","author":"G Ansell","year":"1983","unstructured":"Ansell G, Evans S, Jackson CT et al (1983) Cytotoxic drugs for non-neoplastic disease. Br Med J (Clin Res Ed) 287:762. https:\/\/doi.org\/10.1136\/bmj.287.6394.762-a","journal-title":"Br Med J (Clin Res Ed)"},{"key":"5664_CR5","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"key":"5664_CR6","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"5664_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/ard.52.8.582","volume":"52","author":"SJ Preston","year":"1993","unstructured":"Preston SJ, Diamond T, Scott A, Laurent MR (1993) Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 52:582\u2013585. https:\/\/doi.org\/10.1136\/ard.52.8.582","journal-title":"Ann Rheum Dis"},{"key":"5664_CR8","first-page":"343","volume":"14","author":"C Bologna","year":"1996","unstructured":"Bologna C, Jorgensen C, Sany J (1996) Possible role of methotrexate in the distal tibiae fractures in a patient with rheumatoid arthritis. Clin Exp Rheumatol 14:343\u2013344","journal-title":"Clin Exp Rheumatol"},{"key":"5664_CR9","first-page":"2156","volume":"23","author":"K Maenaut","year":"1996","unstructured":"Maenaut K, Westhovens R, Dequeker J (1996) Methotrexate osteopathy, does it exist? J Rheumatol 23:2156\u20132159","journal-title":"J Rheumatol"},{"key":"5664_CR10","first-page":"508","volume":"65","author":"M Singwe","year":"1998","unstructured":"Singwe M, Le Gars L, Karneff A et al (1998) Multiple stress fractures in a scleroderma patient on methotrexate therapy. Rev Rhum Engl Ed 65:508\u2013510","journal-title":"Rev Rhum Engl Ed"},{"key":"5664_CR11","unstructured":"G\u00fcnay TY, Gari PY, Bodur H (2014) Methotrexate osteopathy in a patient with rheumatoid arthritis: case report. 4"},{"key":"5664_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5704\/MOJ.1511.010","volume":"9","author":"T Tjl","year":"2015","unstructured":"Tjl T, Wls H, Yh T (2015) Sequential proximal Tibial stress fractures associated with prolonged usage of methotrexate and corticosteroids: a case report. MOJ 9:65\u201367. https:\/\/doi.org\/10.5704\/MOJ.1511.010","journal-title":"MOJ"},{"key":"5664_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s002239900585","volume":"64","author":"LD Carbone","year":"1999","unstructured":"Carbone LD, Kaeley G, McKown KM et al (1999) Effects of long-term Administration of Methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64:100\u2013101. https:\/\/doi.org\/10.1007\/s002239900585","journal-title":"Calcif Tissue Int"},{"key":"5664_CR14","unstructured":"Cranney AB, McKendry RJ, Wells GA, et al. (2001) The effect of low dose methotrexate on bone density. Vitamin D 6"},{"key":"5664_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/ard.62.2.186","volume":"62","author":"S Patel","year":"2003","unstructured":"Patel S (2003) Effect of low dose weekly methotrexate on bone mineral density and bone turnover. Ann Rheum Dis 62:186\u2013187. https:\/\/doi.org\/10.1136\/ard.62.2.186","journal-title":"Ann Rheum Dis"},{"key":"5664_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00296-003-0298-z","volume":"23","author":"F Tascioglu","year":"2003","unstructured":"Tascioglu F, Oner C, Armagan O (2003) The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int 23:231\u2013235. https:\/\/doi.org\/10.1007\/s00296-003-0298-z","journal-title":"Rheumatol Int"},{"key":"5664_CR17","first-page":"1305","volume":"31","author":"O Di Munno","year":"2004","unstructured":"Di Munno O, Mazzantini M, Sinigaglia L et al (2004) Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 31:1305\u20131309","journal-title":"J Rheumatol"},{"key":"5664_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/rheumatology\/41.7.741","volume":"41","author":"NJ Minaur","year":"2002","unstructured":"Minaur NJ (2002) Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology 41:741\u2013749. https:\/\/doi.org\/10.1093\/rheumatology\/41.7.741","journal-title":"Rheumatology"},{"key":"5664_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00223-006-0060-0","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Methotrexate, azathioprine, cyclosporine, and risk of fracture. Calcif Tissue Int 79:69\u201375. https:\/\/doi.org\/10.1007\/s00223-006-0060-0","journal-title":"Calcif Tissue Int"},{"key":"5664_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/8756-3282(94)00032-U","volume":"16","author":"DL Wheeler","year":"1995","unstructured":"Wheeler DL, Vander Griend RA, Wronski TJ, Miller GJ, Keith EE, Graves JE (1995) The short- and long-term effects of methotrexate on the rat skeleton. Bone 16:215\u2013221. https:\/\/doi.org\/10.1016\/8756-3282(94)00032-U","journal-title":"Bone"},{"key":"5664_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bone.2007.07.021","volume":"41","author":"CJ Xian","year":"2007","unstructured":"Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK (2007) Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone 41:842\u2013850. https:\/\/doi.org\/10.1016\/j.bone.2007.07.021","journal-title":"Bone"},{"key":"5664_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.1780370208","volume":"37","author":"KP May","year":"1994","unstructured":"May KP, West SG, Mcdermott MT, Huffer WE (1994) The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37:201\u2013206. https:\/\/doi.org\/10.1002\/art.1780370208","journal-title":"Arthritis Rheum"},{"key":"5664_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bone.2008.09.014","volume":"44","author":"C Fan","year":"2009","unstructured":"Fan C, Cool JC, Scherer MA, Foster BK, Shandala T, Tapp H, Xian CJ (2009) Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment. Bone 44:61\u201370. https:\/\/doi.org\/10.1016\/j.bone.2008.09.014","journal-title":"Bone"},{"key":"5664_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajpath.2012.03.037","volume":"181","author":"TJ King","year":"2012","unstructured":"King TJ, Georgiou KR, Cool JC, Scherer MA, Ang ESM, Foster BK, Xu J, Xian CJ (2012) Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-\u03baB activation. Am J Pathol 181:121\u2013129. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.037","journal-title":"Am J Pathol"},{"key":"5664_CR25","doi-asserted-by":"publisher","unstructured":"Liu Y, Cui Y, Chen Y, et al. (2015) Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats. CIA 1245. https:\/\/doi.org\/10.2147\/CIA.S85225","DOI":"10.2147\/CIA.S85225"},{"key":"5664_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jcp.22807","volume":"227","author":"KR Georgiou","year":"2012","unstructured":"Georgiou KR, Scherer MA, Fan C-M, Cool JC, King TJ, Foster BK, Xian CJ (2012) Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow. J Cell Physiol 227:909\u2013918. https:\/\/doi.org\/10.1002\/jcp.22807","journal-title":"J Cell Physiol"},{"key":"5664_CR27","first-page":"1489","volume":"24","author":"LM Buckley","year":"1997","unstructured":"Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24:1489\u20131494","journal-title":"J Rheumatol"},{"key":"5664_CR28","doi-asserted-by":"publisher","first-page":"e0188454","DOI":"10.1371\/journal.pone.0188454","volume":"12","author":"Y-M Chen","year":"2017","unstructured":"Chen Y-M, Chen H-H, Huang W-N, Liao TL, Chen JP, Chao WC, Lin CT, Hung WT, Hsieh CW, Hsieh TY, Chen YH, Chen DY (2017) Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS One 12:e0188454. https:\/\/doi.org\/10.1371\/journal.pone.0188454","journal-title":"PLoS One"},{"key":"5664_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","volume":"78","author":"G Ozen","year":"2019","unstructured":"Ozen G, Pedro S, Wolfe F, Michaud K (2019) Medications associated with fracture risk in patients with rheumatoid arthritis. Ann Rheum Dis 78:1041\u20131047. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215328","journal-title":"Ann Rheum Dis"},{"key":"5664_CR30","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/jcp.23034","volume":"227","author":"T Shandala","year":"2012","unstructured":"Shandala T, Shen Ng Y, Hopwood B, Yip YC, Foster BK, Xian CJ (2012) The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol 227:2889\u20132897. https:\/\/doi.org\/10.1002\/jcp.23034","journal-title":"J Cell Physiol"},{"key":"5664_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jcp.21274","volume":"214","author":"CJ Xian","year":"2008","unstructured":"Xian CJ, Cool JC, Scherer MA, Fan C, Foster BK (2008) Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells. J Cell Physiol 214:777\u2013785. https:\/\/doi.org\/10.1002\/jcp.21274","journal-title":"J Cell Physiol"},{"key":"5664_CR32","doi-asserted-by":"publisher","first-page":"e46915","DOI":"10.1371\/journal.pone.0046915","volume":"7","author":"C-M Fan","year":"2012","unstructured":"Fan C-M, Foster BK, Hui SK, Xian CJ (2012) Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate. PLoS ONE 7:e46915. https:\/\/doi.org\/10.1371\/journal.pone.0046915","journal-title":"PLoS ONE"},{"key":"5664_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.bone.2012.03.027","volume":"50","author":"KR Georgiou","year":"2012","unstructured":"Georgiou KR, King TJ, Scherer MA, Zhou H, Foster BK, Xian CJ (2012) Attenuated Wnt\/\u03b2-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. Bone 50:1223\u20131233. https:\/\/doi.org\/10.1016\/j.bone.2012.03.027","journal-title":"Bone"},{"key":"5664_CR34","first-page":"251","volume":"28","author":"R Uehara","year":"2001","unstructured":"Uehara R, Suzuki Y, Ichikawa Y (2001) Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy. J Rheumatol 28:251\u2013256","journal-title":"J Rheumatol"},{"key":"5664_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/art.1780390317","volume":"39","author":"KP May","year":"1996","unstructured":"May KP, Mercill D, McDermott MT et al (1996) The effect of methotrexate on mouse bone cells in culture. Arthritis Rheum 39:489\u2013494. https:\/\/doi.org\/10.1002\/art.1780390317","journal-title":"Arthritis Rheum"},{"key":"5664_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/35.4.342","volume":"35","author":"MJ Van Der Veen","year":"1996","unstructured":"Van Der Veen MJ, Scheven BAA, Van Roy JLAM et al (1996) Effects of methotrexate on human articular cartilage and bone-derived osteoblasts. Rheumatology 35:342\u2013349. https:\/\/doi.org\/10.1093\/rheumatology\/35.4.342","journal-title":"Rheumatology"},{"key":"5664_CR37","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/jbmr.5650100608","volume":"10","author":"BAA Scheven","year":"1995","unstructured":"Scheven BAA, van der Veen MJ, Damen CA, Lafeber FPJG, van Rijn HJM, Bijlsma JWJ, Duursma SA (1995) Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3. J Bone Miner Res 10:874\u2013880. https:\/\/doi.org\/10.1002\/jbmr.5650100608","journal-title":"J Bone Miner Res"},{"key":"5664_CR38","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/rheumatology\/keh296","volume":"43","author":"KJ Elliot","year":"2004","unstructured":"Elliot KJ (2004) Effects of methotrexate on human bone cell responses to mechanical stimulation. Rheumatology 43:1226\u20131231. https:\/\/doi.org\/10.1093\/rheumatology\/keh296","journal-title":"Rheumatology"},{"key":"5664_CR39","doi-asserted-by":"publisher","first-page":"151422","DOI":"10.1016\/j.aanat.2019.151422","volume":"227","author":"FGF Tresguerres","year":"2020","unstructured":"Tresguerres FGF, Torres J, L\u00f3pez-Quiles J, Hern\u00e1ndez G, Vega JA, Tresguerres IF (2020) The osteocyte: a multifunctional cell within the bone. Ann Anat Anat Anz 227:151422. https:\/\/doi.org\/10.1016\/j.aanat.2019.151422","journal-title":"Ann Anat Anat Anz"},{"key":"5664_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26:229\u2013238. https:\/\/doi.org\/10.1002\/jbmr.320","journal-title":"J Bone Miner Res"},{"key":"5664_CR41","doi-asserted-by":"publisher","unstructured":"Choy VMH, Wong RMY, Chow SKH et al. (2019) How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review. J Orthop Transl S2214031X18302080. doi:https:\/\/doi.org\/10.1016\/j.jot.2019.07.005","DOI":"10.1016\/j.jot.2019.07.005"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-020-05664-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T13:06:11Z","timestamp":1611666371000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-020-05664-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05664-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Fran\u00e7ois Robin, Simon Cadiou, Jean-David Albert, G\u00e9raldine Bart, Guillaume Coiffier, and Pascal Guggenbuhl declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}